Literature DB >> 21160769

Concept of chemoprevention in colorectal cancer.

Colm O'Morain1, Asghar Qasim.   

Abstract

Colorectal cancer remains a significant cause of morbidity and mortality throughout the world. The incidence of colorectal cancer is nearly four-fold higher in more-developed as compared with less-developed regions of the world. At present an early detection of colorectal cancer remains a crucial step in determining the therapeutic outcomes. Screening programmes have been introduced in an effort to detect colorectal cancer at an early stage or at a precancerous colonic polyp stage. These programmes should be used by the health professionals as an opportunity to educate the public regarding the use of chemoprevention in colorectal cancer, which is the main focus of this review and an attractive concept needing further evaluation.

Entities:  

Keywords:  Chemoprevention; Colorectal cancer; Dietary carcinogens; Geographical variations

Year:  2009        PMID: 21160769      PMCID: PMC2999096          DOI: 10.4251/wjgo.v1.i1.21

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  60 in total

1.  Beyond willow bark: aspirin in the prevention of chronic disease.

Authors:  M J Thun
Journal:  Epidemiology       Date:  2000-07       Impact factor: 4.822

2.  Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.

Authors:  Carina L Bos; Sander H Diks; James C H Hardwick; Kimberley V Walburg; Maikel P Peppelenbosch; Dick J Richel
Journal:  Carcinogenesis       Date:  2006-05-25       Impact factor: 4.944

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

4.  Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; L F Watson
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

5.  Rarity of colon cancer in Africans is associated with low animal product consumption, not fiber.

Authors:  S J O'Keefe; M Kidd; G Espitalier-Noel; P Owira
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

Review 6.  Diet and cancer prevention: the roles of observation and experimentation.

Authors:  María Elena Martínez; James R Marshall; Edward Giovannucci
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

7.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

Authors:  P H Gann; J E Manson; R J Glynn; J E Buring; C H Hennekens
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

Review 8.  Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence.

Authors:  Raphaëlle L Santarelli; Fabrice Pierre; Denis E Corpet
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

9.  Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer.

Authors:  M Juarranz; M-E Calle-Purón; A González-Navarro; E Regidor-Poyatos; T Soriano; D Martínez-Hernandez; V-D Rojas; V F Guinee
Journal:  Eur J Cancer Prev       Date:  2002-10       Impact factor: 2.497

10.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

Authors:  Antonio González-Pérez; Luis A García Rodríguez; Ruy López-Ridaura
Journal:  BMC Cancer       Date:  2003-10-31       Impact factor: 4.430

View more
  2 in total

1.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 2.  Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor.

Authors:  Cate Moriasi; Dharmalingam Subramaniam; Shanjana Awasthi; Satish Ramalingam; Shrikant Anant
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.